General Replicel/Shiseido News - Page 10 - BaldTruthTalk.com
+ Reply to Thread
Page 10 of 13 FirstFirst ... 8 9 10 11 12 ... LastLast
Results 91 to 100 of 125
  1. #91
    Senior Member
    Join Date
    May 2015
    Location
    france
    Posts
    395

    Default

    Quote Originally Posted by hellouser View Post
    Hey Lacazette,

    Is there anything you'd want to ask the guys at Replicel during the Hair Congress next month?
    Hey Hellouser, I do'nt tking about something really particular, but maybe I would want to ask a confirmation that their protocol they are working on is suppose to lead to a high number of de novo hair follicles/ HF neogenesis or if it is more in their mind to save the current hair an miniaturized ones

    US army researchers explained that DSC cells can lead to HF neogenesis like DP cells, but maybe it depend on the protocol power/amount of cells, or whatever, so to have a confirmation from them that they work on the real cure would be quite relaxing hehe

    Also if Shiseido have changed/enhanced something in the protocol/type of cells they use, for the trial they will enter or if it is exactly the same of replicel phase 1

    is there somewhere we can donateù? what's going on with that?

  2. #92
    Senior Member PayDay's Avatar
    Join Date
    Nov 2008
    Location
    New York
    Posts
    604

    Default

    I think this answers our questions. Really good interview, that explains a lot. I'm cautiously optimistic after hearing this. https://www.baldtruthtalk.com/thread...ecord-Straight

  3. #93
    Senior Member
    Join Date
    Aug 2012
    Posts
    2,052

    Default

    Any updated on Replicel?

  4. #94
    Junior Member
    Join Date
    Sep 2010
    Location
    NJ
    Posts
    6

    Default

    I have some shares of Replicel and periodically check in to see if there are any updates on their clinical trials and such. Even though the stock is taking a beating right now, the CEO put forth a statement some time ago that offers some clarity on a target date for release in Japan. Check it out:

    "A company in transition. RepliCel is transitioning from an early-stage biotech company to one with commercial products.
    Today we sit as an early-stage biotech company but one with a rapidly maturing and diversified portfolio of products in development characterized by:
    three products in active clinical trials, two of which (RCT-01 & RCS-01) are anticipated to generate clinical data by year-end,
    a medical device (RCI-02) in late-stage development which is on-track to be launched to the market in 2017, licensing discussion with major international companies are underway, and
    a major international licensing and co-development partnership in place around a product being co-developed with that partner which has the potential to be on the market in Japan in 2018.
    2016 promises to be an important year for RepliCel. Over the next 12-15 months, everything we've been working on over the past 36 months has material milestones including:
    clinical data from both our RCT-01 (chronic tendon injury) and RCS-01 (aging and sub-damaged skin) clinical trials in late 2016,
    Shiseido launching their next-phase clinical trial of RCH-01 (pattern baldness) in Japan in early 2016. This is expected to be approximately a 20-month trial and has the potential to lead to a market launch in 2018 in Japan, and
    filing a CE mark application for our dermal injector (RCI-02) seeking permission to sell the device in Europe with label approval for injection of hyaluronic acid-based dermal fillers."

  5. #95
    Junior Member
    Join Date
    Sep 2010
    Location
    NJ
    Posts
    6

    Default

    I have some shares of Replicel and periodically check in to see if there are any updates on their clinical trials and such. Even though the stock is taking a beating right now, the CEO put forth a statement some time ago that offers some clarity on a target date for release in Japan. Check it out:

    "A company in transition. RepliCel is transitioning from an early-stage biotech company to one with commercial products.
    Today we sit as an early-stage biotech company but one with a rapidly maturing and diversified portfolio of products in development characterized by:
    three products in active clinical trials, two of which (RCT-01 & RCS-01) are anticipated to generate clinical data by year-end,
    a medical device (RCI-02) in late-stage development which is on-track to be launched to the market in 2017, licensing discussion with major international companies are underway, and
    a major international licensing and co-development partnership in place around a product being co-developed with that partner which has the potential to be on the market in Japan in 2018.
    2016 promises to be an important year for RepliCel. Over the next 12-15 months, everything we've been working on over the past 36 months has material milestones including:
    clinical data from both our RCT-01 (chronic tendon injury) and RCS-01 (aging and sub-damaged skin) clinical trials in late 2016,
    Shiseido launching their next-phase clinical trial of RCH-01 (pattern baldness) in Japan in early 2016. This is expected to be approximately a 20-month trial and has the potential to lead to a market launch in 2018 in Japan, and
    filing a CE mark application for our dermal injector (RCI-02) seeking permission to sell the device in Europe with label approval for injection of hyaluronic acid-based dermal fillers."

  6. #96
    Senior Member Breaking Bald's Avatar
    Join Date
    Aug 2012
    Location
    At wits end...
    Posts
    593

    Default

    This is a good sign, right!?

  7. #97
    Senior Member
    Join Date
    Aug 2012
    Posts
    2,052

    Default

    Awesome .

  8. #98
    Junior Member
    Join Date
    Apr 2016
    Posts
    1

    Default

    lol - i remember when Replicel said the treatment could be availabel mid 2015 in Japan, then they kept putting back the clinical trials, then eventually they abandoned them.

  9. #99
    Member
    Join Date
    Jan 2015
    Posts
    38

    Default

    In a month it's going to be the middle of 2016 lol they need to get their crap together

  10. #100
    Member
    Join Date
    Sep 2010
    Posts
    99

    Default

    1000 dollars for the treatment.

Similar Threads

  1. Replies: 175
    Last Post: 03-07-2015, 07:21 AM
  2. Replies: 44
    Last Post: 12-19-2014, 02:34 PM
  3. Big Replicel News!!
    By UK Boy in forum Cutting Edge / Future Treatments
    Replies: 97
    Last Post: 09-03-2013, 02:17 PM
  4. Replicel and Shiseido Collaboration Technology Transfer Agreement for treating MPB
    By TravisB in forum Cutting Edge / Future Treatments
    Replies: 7
    Last Post: 07-12-2013, 03:39 PM
  5. Big Replicel news
    By Andrewzarian in forum Cutting Edge / Future Treatments
    Replies: 50
    Last Post: 05-14-2013, 11:35 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts

» IAHRS

hair transplant surgeons

» The Bald Truth

» Recent Threads

Which is the best Salesforce institutes in Hyderabad?
03-17-2024 09:59 AM
Last Post By palashmim2022
03-17-2024 09:59 AM
The Resveratrol microneedling process study - enroll now
04-11-2022 02:38 AM
Last Post By Briam1930
03-16-2024 05:43 AM
What wedding packages are offered in Tbilisi?
01-27-2024 04:13 AM
by Jiromen
Last Post By Henryclark
03-16-2024 03:12 AM
Tour Operator's Treasures in Bangladesh
09-28-2023 06:48 AM
by davidm
Last Post By Briam1930
03-16-2024 12:49 AM